Patents by Inventor Timothy Robin Hammonds

Timothy Robin Hammonds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDINE BENZAMIDES AND PYRAZINE BENZAMIDES USED AS PKD INHIBITORS
    Publication number: 20110098325
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain pyridine benzamide and pyrazine benzamide compounds (referred to herein as PDBA and PZBA compounds) which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 28, 2011
    Applicant: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Tony Michael Raynham, Timothy Robin Hammonds, Mark David Charles, Grégoire Alexandre Pave, Caroline Heather Foxton, Wesley Peter Blackaby, Adrian Philip Stevens, Chukuemeka Tennyson Ekwuru
  • AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE
    Publication number: 20090247519
    Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain amino-ethyl-amino-aryl (AEAA) compounds which, inter alia, inhibit protein kinase D (PKD) (e.g., PKD1, PKD2, PKD3). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit PKD, and in the treatment of diseases and conditions that are mediated by PKD, that are ameliorated by the inhibition of PKD, etc., including proliferative conditions such as cancer, etc.
    Type: Application
    Filed: April 26, 2007
    Publication date: October 1, 2009
    Inventors: Tony Michael Raynham, Timothy Robin Hammonds, Julia Helen Gilliatt, Mark David Charles, Gregoire Alexandre Pave, Caroline Heather Foxton, James Lindsay Carr, Neela Sumit Mistry